mRNA Vaccine and Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers mRNA Therapeutics Manufacturing Companies and it is Segmented by Vaccine Type (Self-amplifying mRNA-based Vaccines and Conventional Non-amplifying mRNA-based Vaccines), Application (Cancer, Infectious Diseases, Autoimmune Diseases, and Other Applications), Treatment Type (Monoclonal Antibody, Gene Therapy, Cell Therapy, and Other Treatment Types), End User (Research Laboratories and Organizations, Hospitals, and Clinics and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

mRNA Vaccine and Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

mRNA Vaccine and Therapeutics Industry Overview

The market for mRNA vaccines and therapeutics is fragmented in nature due to the presence of several companies globally. Key players are implementing various strategies, including partnerships, mergers and acquisitions, geographic expansion, and strategic collaborations to expand their market presence. Some of the key companies dealing in the market studied are AstraZeneca, Pfizer Inc., Moderna, BioNTech, GlaxoSmithKline, Daiichi Sankyo, BioNTech SE, and among others.

mRNA Vaccine and Therapeutics Market Leaders

  1. Pfizer Inc.

  2. Moderna, Inc.

  3. BioNTech SE

  4. GlaxoSmithKline

  5. Daiichi Sankyo 

  6. *Disclaimer: Major Players sorted in no particular order
mRNA Vaccines and Therapeutics Market Concentration

mRNA Vaccine and Therapeutics Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?